Yuhan Corporation Preferred Stock (000105) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yuhan Corporation Preferred Stock (000105:KRX), powered by AI.

Current Price
₩66,200
P/E Ratio
0.4
Market Cap
78.2B
Sector
Healthcare
What is the Yuhan Corporation Preferred Stock stock price forecast?

Yuhan Corporation Preferred Stock is currently trading at ₩66,200. View real-time AI analysis on Alpha Lenz.

What is Yuhan Corporation Preferred Stock insider trading activity?

View the latest insider trading data for Yuhan Corporation Preferred Stock on Alpha Lenz.

What is Yuhan Corporation Preferred Stock's P/E ratio?

Yuhan Corporation Preferred Stock's P/E ratio is 0.4.

Yuhan Corporation Preferred Stock

KRX · 000105
₩66,200+2,200(+3.44%)Market closedKRX regular session 09:00–15:30 KST
Ask about Yuhan Corporation Preferred Stock's future dividend policy...
Alpha Chat Insight

Yuhan Corporation Preferred Stock trades at a P/E of 0.4 (undervalued) with solid ROE of 8.8%.

Ask for details

Company Overview

Yuhan Corporation Preferred Stock represents a class of shares issued by Yuhan Corporation, a South Korean pharmaceutical and healthcare company. This type of stock gives investors a higher claim on the company's assets and earnings compared to common stockholders. With preferred shares, investors typically receive fixed dividends that are paid out before any dividends on the company's common stock are issued. Yuhan Corporation is renowned for its production of pharmaceuticals, biotechnology products, and health supplements, contributing significantly to sectors such as healthcare, life sciences, and pharmaceuticals. The preferred stock is particularly suited for stakeholders seeking more stable income through dividends, due to its prioritized payout structure. In the financial market, Yuhan Corporation Preferred Stock plays a vital role by offering investors an instrument that balances growth potential in the healthcare industry with the relatively secure returns of preferred dividends. This stock therefore attracts both institutional and individual investors focusing on stable income with reduced risk, as they participate indirectly in the burgeoning pharmaceutical sector of South Korea.

CEOMr. Wook-Je Cho
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees2,038

Company Statistics

FY 2025

Profile

₩78,178,228,000Market Cap
₩2,186,637,586,350Revenue
1.18MShares Out
2,038Employees

Margins

33.38%Gross
14.40%EBITDA
4.77%Operating
10.18%Pre-Tax
8.48%Net

Valuation

0.40P/E
0.03P/B
0.04EV/Sales
0.40EV/EBITDA
-2.03P/FCF

Growth (CAGR)

7.18%Rev 3Yr
6.18%Rev 5Yr
42.55%Op Inc 3Yr
4.38%Op Inc 5Yr
26.94%Net Inc 3Yr
-0.54%Net Inc 5Yr

Returns

6.01%ROA
8.81%ROE
7.73%ROIC

Financial Health

₩348,564,938,250Cash & Cash Equivalents
₩510,076,559,980Net Debt
36.35%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Yuhan Corporation Preferred Stock (ticker: 000105) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 2,038 employees. Market cap is $78.2B.

The current price is ₩66,200 with a P/E ratio of 0.4x and P/B of 0.03x.

ROE is 8.81% and operating margin is 4.77%. Annual revenue is $2.2T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Yuhan Corporation Preferred Stock (000105) Stock Forecast 2026 ₩66,200 — Price, Financials & Analyst Targets | Alpha Lenz